AlphaQuest LLC Sells 15,439 Shares of Encompass Health Corporation $EHC

Key Points

• AlphaQuest LLC cut its Encompass Health position by 51.6% in the fourth quarter, selling 15,439 shares and leaving it with 14,477 shares valued at about $1.54 million.
• Recent analyst activity remains generally positive: Encompass Health has a consensus rating of “Buy” with an average price target of $145.29, though Barclays trimmed its target to $140.
• The company reported better-than-expected quarterly results, with EPS of $1.60 versus $1.51 estimated and revenue up 9% year over year; it also announced a quarterly dividend of $0.19 per share.

AlphaQuest LLC reduced its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 51.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,477 shares of the company's stock after selling 15,439 shares during the period. AlphaQuest LLC's holdings in Encompass Health were worth $1,537,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in EHC. Westside Investment Management Inc. grew its holdings in shares of Encompass Health by 56.7% during the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company's stock worth $35,000 after purchasing an additional 101 shares in the last quarter. Assetmark Inc. grew its holdings in shares of Encompass Health by 88.1% during the 3rd quarter. Assetmark Inc. now owns 299 shares of the company's stock worth $38,000 after purchasing an additional 140 shares in the last quarter. WPG Advisers LLC grew its holdings in shares of Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company's stock worth $34,000 after purchasing an additional 137 shares in the last quarter. Flagship Harbor Advisors LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth approximately $37,000. Finally, Caitong International Asset Management Co. Ltd grew its holdings in shares of Encompass Health by 36,200.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company's stock worth $46,000 after purchasing an additional 362 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Barclays decreased their price objective on Encompass Health from $153.00 to $140.00 and set an "overweight" rating on the stock in a report on Tuesday, May 5th. Leerink Partners set a $152.00 price objective on Encompass Health in a report on Friday, May 22nd. Finally, Wall Street Zen raised Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, May 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $145.29.

Insiders Place Their Bets

In other news, Treasurer Edmund Fay sold 11,937 shares of the business's stock in a transaction on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the sale, the treasurer owned 89,325 shares in the company, valued at $9,557,775. The trade was a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Patrick William Tuer sold 682 shares of the business's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president owned 24,755 shares of the company's stock, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 1.80% of the company's stock.

Encompass Health Trading Down 0.5%

Shares of EHC opened at $104.40 on Thursday. The stock has a fifty day moving average price of $103.10 and a two-hundred day moving average price of $105.50. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99. The company has a market cap of $10.36 billion, a price-to-earnings ratio of 17.43, a PEG ratio of 2.29 and a beta of 0.72.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the previous year, the company posted $1.37 EPS. The business's revenue for the quarter was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Analysts predict that Encompass Health Corporation will post 5.96 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a dividend of $0.19 per share. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health's payout ratio is presently 12.69%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.